Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure. 1978

J Mehta, and M Iacona, and R L Feldman, and C J Pepine, and C R Conti

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009599 Nitroprusside A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins. Nitroferricyanide,Sodium Nitroprusside,Cyanonitrosylferrate,Ketostix,Naniprus,Nipride,Nipruton,Nitriate,Nitropress,Nitroprussiat Fides,Nitroprusside, Disodium Salt,Nitroprusside, Disodium Salt, Dihydrate,Disodium Salt Nitroprusside,Nitroprusside, Sodium
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D011652 Pulmonary Circulation The circulation of the BLOOD through the LUNGS. Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation

Related Publications

J Mehta, and M Iacona, and R L Feldman, and C J Pepine, and C R Conti
November 1979, La Nouvelle presse medicale,
J Mehta, and M Iacona, and R L Feldman, and C J Pepine, and C R Conti
May 1981, Kokyu to junkan. Respiration & circulation,
J Mehta, and M Iacona, and R L Feldman, and C J Pepine, and C R Conti
January 1980, Giornale italiano di cardiologia,
J Mehta, and M Iacona, and R L Feldman, and C J Pepine, and C R Conti
January 1997, Likars'ka sprava,
J Mehta, and M Iacona, and R L Feldman, and C J Pepine, and C R Conti
September 1981, American heart journal,
J Mehta, and M Iacona, and R L Feldman, and C J Pepine, and C R Conti
December 1984, Zhonghua xin xue guan bing za zhi,
J Mehta, and M Iacona, and R L Feldman, and C J Pepine, and C R Conti
November 1980, Japanese heart journal,
J Mehta, and M Iacona, and R L Feldman, and C J Pepine, and C R Conti
September 1982, American heart journal,
J Mehta, and M Iacona, and R L Feldman, and C J Pepine, and C R Conti
June 1980, Archives des maladies du coeur et des vaisseaux,
Copied contents to your clipboard!